EMERYVILLE, Calif., Sept. 7, 2010 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing its proprietary and patented Aganocide® compounds (NYSE Amex:NBY), announces that Thomas Paulson, CFO, will present at the Rodman & Renshaw Annual Global Investment Conference. The presentation is currently scheduled for 12:05 PM, September 14, 2010, in the Fahnestock Salon, 5th Floor of the New York Palace Hotel in New York City.
